CTCF, WAPL and PDS5 Proteins Control the Formation of Tads and Loops by Cohesin
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Mutational Inactivation of STAG2 Causes Aneuploidy in Human Cancer
REPORTS mean difference for all rubric score elements was ing becomes a more commonly supported facet 18. C. L. Townsend, E. Heit, Mem. Cognit. 39, 204 (2011). rejected. Univariate statistical tests of the observed of STEM graduate education then students’ in- 19. D. F. Feldon, M. Maher, B. Timmerman, Science 329, 282 (2010). mean differences between the teaching-and- structional training and experiences would alle- 20. B. Timmerman et al., Assess. Eval. High. Educ. 36,509 research and research-only conditions indicated viate persistent concerns that current programs (2011). significant results for the rubric score elements underprepare future STEM faculty to perform 21. No outcome differences were detected as a function of “testability of hypotheses” [mean difference = their teaching responsibilities (28, 29). the type of teaching experience (TA or GK-12) within the P sample population participating in both research and 0.272, = 0.006; CI = (.106, 0.526)] with the null teaching. hypothesis rejected in 99.3% of generated data References and Notes 22. Materials and methods are available as supporting samples (Fig. 1) and “research/experimental de- 1. W. A. Anderson et al., Science 331, 152 (2011). material on Science Online. ” P 2. J. A. Bianchini, D. J. Whitney, T. D. Breton, B. A. Hilton-Brown, 23. R. L. Johnson, J. Penny, B. Gordon, Appl. Meas. Educ. 13, sign [mean difference = 0.317, = 0.002; CI = Sci. Educ. 86, 42 (2001). (.106, 0.522)] with the null hypothesis rejected in 121 (2000). 3. C. E. Brawner, R. M. Felder, R. Allen, R. Brent, 24. R. J. A. Little, J. -
Identification of Key Pathways and Genes in Endometrial Cancer Using Bioinformatics Analyses
ONCOLOGY LETTERS 17: 897-906, 2019 Identification of key pathways and genes in endometrial cancer using bioinformatics analyses YAN LIU, TENG HUA, SHUQI CHI and HONGBO WANG Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China Received March 16, 2018; Accepted October 12, 2018 DOI: 10.3892/ol.2018.9667 Abstract. Endometrial cancer (EC) is one of the most Introduction common gynecological cancer types worldwide. However, to the best of our knowledge, its underlying mechanisms Endometrial carcinoma (EC) is one of the most common remain unknown. The current study downloaded three mRNA gynecological cancer types, with increasing global incidence and microRNA (miRNA) datasets of EC and normal tissue in recent years (1). A total of 60,050 cases of EC and 10,470 samples, GSE17025, GSE63678 and GSE35794, from the EC-associated cases of mortality were reported in the USA in Gene Expression Omnibus to identify differentially expressed 2016 (1), which was markedly higher than the 2012 statistics genes (DEGs) and miRNAs (DEMs) in EC tumor tissues. of 47,130 cases and 8,010 mortalities (2). Although numerous The DEGs and DEMs were then validated using data from studies have been conducted to investigate the mechanisms of The Cancer Genome Atlas and subjected to gene ontology endometrial tumorigenesis and development, to the best of our and Kyoto Encyclopedia of Genes and Genomes pathway knowledge, the exact etiology remains unknown. Understanding analysis. STRING and Cytoscape were used to construct a the potential molecular mechanisms underlying EC initiation protein-protein interaction network and the prognostic effects and progression is of great clinical significance. -
Redundant and Specific Roles of Cohesin STAG Subunits in Chromatin Looping and Transcriptional Control
Downloaded from genome.cshlp.org on October 10, 2021 - Published by Cold Spring Harbor Laboratory Press Research Redundant and specific roles of cohesin STAG subunits in chromatin looping and transcriptional control Valentina Casa,1,6 Macarena Moronta Gines,1,6 Eduardo Gade Gusmao,2,3,6 Johan A. Slotman,4 Anne Zirkel,2 Natasa Josipovic,2,3 Edwin Oole,5 Wilfred F.J. van IJcken,1,5 Adriaan B. Houtsmuller,4 Argyris Papantonis,2,3 and Kerstin S. Wendt1 1Department of Cell Biology, Erasmus MC, 3015 GD Rotterdam, The Netherlands; 2Center for Molecular Medicine Cologne, University of Cologne, 50931 Cologne, Germany; 3Institute of Pathology, University Medical Center, Georg-August University of Göttingen, 37075 Göttingen, Germany; 4Optical Imaging Centre, Erasmus MC, 3015 GD Rotterdam, The Netherlands; 5Center for Biomics, Erasmus MC, 3015 GD Rotterdam, The Netherlands Cohesin is a ring-shaped multiprotein complex that is crucial for 3D genome organization and transcriptional regulation during differentiation and development. It also confers sister chromatid cohesion and facilitates DNA damage repair. Besides its core subunits SMC3, SMC1A, and RAD21, cohesin in somatic cells contains one of two orthologous STAG sub- units, STAG1 or STAG2. How these variable subunits affect the function of the cohesin complex is still unclear. STAG1- and STAG2-cohesin were initially proposed to organize cohesion at telomeres and centromeres, respectively. Here, we uncover redundant and specific roles of STAG1 and STAG2 in gene regulation and chromatin looping using HCT116 cells with an auxin-inducible degron (AID) tag fused to either STAG1 or STAG2. Following rapid depletion of either subunit, we perform high-resolution Hi-C, gene expression, and sequential ChIP studies to show that STAG1 and STAG2 do not co-occupy in- dividual binding sites and have distinct ways by which they affect looping and gene expression. -
Table SI. Genes Upregulated ≥ 2-Fold by MIH 2.4Bl Treatment Affymetrix ID
Table SI. Genes upregulated 2-fold by MIH 2.4Bl treatment Fold UniGene ID Description Affymetrix ID Entrez Gene Change 1558048_x_at 28.84 Hs.551290 231597_x_at 17.02 Hs.720692 238825_at 10.19 93953 Hs.135167 acidic repeat containing (ACRC) 203821_at 9.82 1839 Hs.799 heparin binding EGF like growth factor (HBEGF) 1559509_at 9.41 Hs.656636 202957_at 9.06 3059 Hs.14601 hematopoietic cell-specific Lyn substrate 1 (HCLS1) 202388_at 8.11 5997 Hs.78944 regulator of G-protein signaling 2 (RGS2) 213649_at 7.9 6432 Hs.309090 serine and arginine rich splicing factor 7 (SRSF7) 228262_at 7.83 256714 Hs.127951 MAP7 domain containing 2 (MAP7D2) 38037_at 7.75 1839 Hs.799 heparin binding EGF like growth factor (HBEGF) 224549_x_at 7.6 202672_s_at 7.53 467 Hs.460 activating transcription factor 3 (ATF3) 243581_at 6.94 Hs.659284 239203_at 6.9 286006 Hs.396189 leucine rich single-pass membrane protein 1 (LSMEM1) 210800_at 6.7 1678 translocase of inner mitochondrial membrane 8 homolog A (yeast) (TIMM8A) 238956_at 6.48 1943 Hs.741510 ephrin A2 (EFNA2) 242918_at 6.22 4678 Hs.319334 nuclear autoantigenic sperm protein (NASP) 224254_x_at 6.06 243509_at 6 236832_at 5.89 221442 Hs.374076 adenylate cyclase 10, soluble pseudogene 1 (ADCY10P1) 234562_x_at 5.89 Hs.675414 214093_s_at 5.88 8880 Hs.567380; far upstream element binding protein 1 (FUBP1) Hs.707742 223774_at 5.59 677825 Hs.632377 small nucleolar RNA, H/ACA box 44 (SNORA44) 234723_x_at 5.48 Hs.677287 226419_s_at 5.41 6426 Hs.710026; serine and arginine rich splicing factor 1 (SRSF1) Hs.744140 228967_at 5.37 -
Rabbit Anti-CDCA5/FITC Conjugated Antibody
SunLong Biotech Co.,LTD Tel: 0086-571- 56623320 Fax:0086-571- 56623318 E-mail:[email protected] www.sunlongbiotech.com Rabbit Anti-CDCA5/FITC Conjugated antibody SL7717R-FITC Product Name: Anti-CDCA5/FITC Chinese Name: FITC标记的细胞分裂周期相关蛋白5抗体 Alias: Cell division cycle associated protein 5; MGC16386; p35; Sororin; CDCA5_HUMAN. Organism Species: Rabbit Clonality: Polyclonal React Species: Human,Mouse,Rat,Dog,Pig,Cow,Horse,Rabbit, Flow-Cyt=1:50-200IF=1:50-200 Applications: not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. Molecular weight: 28kDa Form: Lyophilized or Liquid Concentration: 1mg/ml immunogen: KLH conjugated synthetic peptide derived from human CDCA5 Lsotype: IgG Purification: affinity purified by Protein A Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibodywww.sunlongbiotech.com is stable at room temperature for at least one month and for greater than a year Storage: when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. background: Sororin, also designated cell division cycle-associated protein 5 (CDCA5) or p35, functions as a regulator of sister chromatid cohesion during mitosis. It interacts with the APC/C complex and is found in a complex consisting of cohesion components SCC- 112, MC1L1, SMC3L1, RAD21 and APRIN. The deduced human and mouse Sororin Product Detail: proteins consist of 252 and 264 amino acid residues, respectively, and both contain a KEN box for APC-dependent ubiquitination. -
Low Tolerance for Transcriptional Variation at Cohesin Genes Is Accompanied by Functional Links to Disease-Relevant Pathways
bioRxiv preprint doi: https://doi.org/10.1101/2020.04.11.037358; this version posted April 13, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Title Low tolerance for transcriptional variation at cohesin genes is accompanied by functional links to disease-relevant pathways Authors William Schierdingǂ1, Julia Horsfieldǂ2,3, Justin O’Sullivan1,3,4 ǂTo whom correspondence should be addressed. 1 Liggins Institute, The University of Auckland, Auckland, New Zealand 2 Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand 3 The Maurice Wilkins Centre for Biodiscovery, The University of Auckland, Auckland, New Zealand 4 MRC Lifecourse Epidemiology Unit, University of Southampton Acknowledgements This work was supported by a Royal Society of New Zealand Marsden Grant to JH and JOS (16-UOO- 072), and WS was supported by the same grant. Contributions WS planned the study, performed analyses, and drafted the manuscript. JH and JOS revised the manuscript. Competing interests None declared. bioRxiv preprint doi: https://doi.org/10.1101/2020.04.11.037358; this version posted April 13, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Abstract Variants in DNA regulatory elements can alter the regulation of distant genes through spatial- regulatory connections. -
Gene Regulation by Cohesin in Cancer: Is the Ring an Unexpected Party to Proliferation?
Published OnlineFirst September 22, 2011; DOI: 10.1158/1541-7786.MCR-11-0382 Molecular Cancer Review Research Gene Regulation by Cohesin in Cancer: Is the Ring an Unexpected Party to Proliferation? Jenny M. Rhodes, Miranda McEwan, and Julia A. Horsfield Abstract Cohesin is a multisubunit protein complex that plays an integral role in sister chromatid cohesion, DNA repair, and meiosis. Of significance, both over- and underexpression of cohesin are associated with cancer. It is generally believed that cohesin dysregulation contributes to cancer by leading to aneuploidy or chromosome instability. For cancers with loss of cohesin function, this idea seems plausible. However, overexpression of cohesin in cancer appears to be more significant for prognosis than its loss. Increased levels of cohesin subunits correlate with poor prognosis and resistance to drug, hormone, and radiation therapies. However, if there is sufficient cohesin for sister chromatid cohesion, overexpression of cohesin subunits should not obligatorily lead to aneuploidy. This raises the possibility that excess cohesin promotes cancer by alternative mechanisms. Over the last decade, it has emerged that cohesin regulates gene transcription. Recent studies have shown that gene regulation by cohesin contributes to stem cell pluripotency and cell differentiation. Of importance, cohesin positively regulates the transcription of genes known to be dysregulated in cancer, such as Runx1, Runx3, and Myc. Furthermore, cohesin binds with estrogen receptor a throughout the genome in breast cancer cells, suggesting that it may be involved in the transcription of estrogen-responsive genes. Here, we will review evidence supporting the idea that the gene regulation func- tion of cohesin represents a previously unrecognized mechanism for the development of cancer. -
The Expanding Universe of Cohesin Functions: a New Genome Stability Caretaker Involved in Human Disease and Cancer
THE EXPANDING UNIVERSE OF COHESIN FUNCTIONS: A NEW GENOME STABILITY CARETAKER INVOLVED IN HUMAN DISEASE AND CANCER. Linda Mannini, Stefania Menga, Antonio Musio To cite this version: Linda Mannini, Stefania Menga, Antonio Musio. THE EXPANDING UNIVERSE OF COHESIN FUNCTIONS: A NEW GENOME STABILITY CARETAKER INVOLVED IN HUMAN DISEASE AND CANCER.. Human Mutation, Wiley, 2010, 31 (6), pp.623. 10.1002/humu.21252. hal- 00552379 HAL Id: hal-00552379 https://hal.archives-ouvertes.fr/hal-00552379 Submitted on 6 Jan 2011 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Human Mutation THE EXPANDING UNIVERSE OF COHESIN FUNCTIONS: A NEW GENOME STABILITY CARETAKER INVOLVED IN HUMAN DISEASE AND CANCER. For Peer Review Journal: Human Mutation Manuscript ID: humu-2009-0533.R3 Wiley - Manuscript type: Review Date Submitted by the 02-Mar-2010 Author: Complete List of Authors: Mannini, Linda; Istituto di Tecnologie Biomediche C.N.R., Unita' di Pisa Menga, Stefania; Istituto di Tecnologie Biomediche C.N.R., Unita' di Pisa Musio, Antonio; Istituto di Tecnologie Biomediche C.N.R., Unita' di Pisa Cohesin, Cornelia de Lange syndrome, Roberts syndrome , Genome Key Words: instability, Cancer John Wiley & Sons, Inc. -
Homozygosity Mapping in Sheep Affected by Cervicothoracic Vertebral Subluxation: Candidate Gene Identification and Novel Mutation Investigation
HOMOZYGOSITY MAPPING IN SHEEP AFFECTED BY CERVICOTHORACIC VERTEBRAL SUBLUXATION: CANDIDATE GENE IDENTIFICATION AND NOVEL MUTATION INVESTIGATION RACHEL L. TULLOCH1, BRENDON A. O’ROURKE2, SHERNAE A. WOOLLEY1, MEHAR S. KHATKAR1 and IMKE TAMMEN1 Summary Cervicothoracic vertebral subluxation (CVS) is an inherited disorder affecting Merino sheep. Affected animals exhibit sudden onset of ataxia in sheep from 9 months to 3 years of age, the disorder is of an economic and welfare concern to the industry. The prevalence of this disorder both nationally and internationally is unknown due to its ambiguous phenotype. This is the first study to map investigate genetic variations as a likely cause of CVS in Merino sheep. Twelve clinically affected animals from two separate Australian properties (Riverina, NSW, and Central West, NSW) were sampled and genotyped using the Illumina® OvineSNP50 BeadChip. The PDS5 homologue B gene was identified as a positional candidate gene using a homozygosity mapping approach. Sanger sequencing of RT-PCR products was utilised to sequence cDNA of the candidate gene in an affected animal. DNA sequencing revealed four variants within the candidate gene when compared to a reference sequence (GenBank® XM_015098134), a 6pb insertion (3619_3620insGTAAGG), two possible missense mutations (3412_C>A; 4342A>T) and an exon deletion (4066del-exon33). The 6bp insertion has been previously catalogued in other reference genomes, the two missense mutations appear to be a novel identification and the exon 33 deletion may represent a splice variant. Further analysis is required to confirm if any variant is pathogenic. A diagnostic test may be developed using information about associated SNP or after confirmation of a disease casing variant in the PDS5B gene. -
Research Article Integrative Genomics Identified RFC3 As an Amplified
Author Manuscript Published OnlineFirst on February 10, 2012; DOI: 10.1158/1078-0432.CCR-11-1431 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Research Article Integrative Genomics Identified RFC3 as an Amplified Candidate Oncogene in Esophageal Adenocarcinoma William W. Lockwood1,2,3*, Kelsie L. Thu1,3, Lin Lin4, Larissa A. Pikor1, Raj Chari1,5, Wan L. Lam1† and David G. Beer4† 1Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, BC, Canada 2Current Affiliation: National Human Genome Research Institute - NIH, Bethesda, Maryland, USA 4Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA 5Current Affiliation: Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA 3These authors contributed equally † These principal investigators contributed equally Running Title: RFC3 Activation in Esophageal Cancer Keywords: RFC3; esophageal adenocarcinoma; Barrett's esophagus; DNA amplification Financial Support: Canadian Institutes of Health Research, Canadian Cancer Society and Vanier Canada Graduate Scholarship. *Corresponding author: William W. Lockwood, Cancer Genetics Branch, National Human Genome Research Institute, NIH, 50 South Drive, Bethesda, MD USA 20892. Phone: (301) 594- 9773. Fax: (301) 443-9139. E-mail: [email protected] Disclosures: The authors have nothing to disclose. Word Count: 4,745 Total Number of Figures and Tables: 6 Transcript Profiling: GEO Accession Numbers: GSE22524, GSE1420, GSE19417, GSE2845, GSE3141. caArray: jacob-00182. caBIG (https://cabig.nci.nih.gov/tools/caArray_GSKdata). Wellcome Trust Sanger Institute CGP Data Archive (sanger.ac.uk/genetics/CGP/Archive/) 1 Downloaded from clincancerres.aacrjournals.org on September 28, 2021. © 2012 American Association for Cancer Research. Author Manuscript Published OnlineFirst on February 10, 2012; DOI: 10.1158/1078-0432.CCR-11-1431 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. -
A High-Throughput Approach to Uncover Novel Roles of APOBEC2, a Functional Orphan of the AID/APOBEC Family
Rockefeller University Digital Commons @ RU Student Theses and Dissertations 2018 A High-Throughput Approach to Uncover Novel Roles of APOBEC2, a Functional Orphan of the AID/APOBEC Family Linda Molla Follow this and additional works at: https://digitalcommons.rockefeller.edu/ student_theses_and_dissertations Part of the Life Sciences Commons A HIGH-THROUGHPUT APPROACH TO UNCOVER NOVEL ROLES OF APOBEC2, A FUNCTIONAL ORPHAN OF THE AID/APOBEC FAMILY A Thesis Presented to the Faculty of The Rockefeller University in Partial Fulfillment of the Requirements for the degree of Doctor of Philosophy by Linda Molla June 2018 © Copyright by Linda Molla 2018 A HIGH-THROUGHPUT APPROACH TO UNCOVER NOVEL ROLES OF APOBEC2, A FUNCTIONAL ORPHAN OF THE AID/APOBEC FAMILY Linda Molla, Ph.D. The Rockefeller University 2018 APOBEC2 is a member of the AID/APOBEC cytidine deaminase family of proteins. Unlike most of AID/APOBEC, however, APOBEC2’s function remains elusive. Previous research has implicated APOBEC2 in diverse organisms and cellular processes such as muscle biology (in Mus musculus), regeneration (in Danio rerio), and development (in Xenopus laevis). APOBEC2 has also been implicated in cancer. However the enzymatic activity, substrate or physiological target(s) of APOBEC2 are unknown. For this thesis, I have combined Next Generation Sequencing (NGS) techniques with state-of-the-art molecular biology to determine the physiological targets of APOBEC2. Using a cell culture muscle differentiation system, and RNA sequencing (RNA-Seq) by polyA capture, I demonstrated that unlike the AID/APOBEC family member APOBEC1, APOBEC2 is not an RNA editor. Using the same system combined with enhanced Reduced Representation Bisulfite Sequencing (eRRBS) analyses I showed that, unlike the AID/APOBEC family member AID, APOBEC2 does not act as a 5-methyl-C deaminase. -
PDS5B Regulates Cell Proliferation and Motility Via Upregulation of Ptch2 In
Cancer Letters 460 (2019) 65–74 Contents lists available at ScienceDirect Cancer Letters journal homepage: www.elsevier.com/locate/canlet Original Articles PDS5B regulates cell proliferation and motility via upregulation of Ptch2 in T pancreatic cancer cells ∗∗ ∗ Jia Maa, ,1, Yue Cuib,1, Tong Caoc, Hui Xud, Ying Shia, Jun Xiaa, Yisheng Taoe, Z. Peter Wanga,f, a Department of Biochemistry and Molecular Biology, School of Laboratory Medicine, Bengbu Medical College, Anhui, 233030, China b Research Center of Clinical Laboratory Science, Bengbu Medical College, Anhui, China, 233030, China c Department of Clinical Laboratory, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, 233004, China d Department of Laboratory Medicine, Bengbu Medical College, Anhui, 233030, China e Department of Pathology, The First Affiliated Hospital of Bengbu Medical College, Anhui, China, 233030, China f Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, 02115, MA, USA ARTICLE INFO ABSTRACT Keywords: Pds5b (precocious dissociation of sisters 5B) is involved in both tumorigenesis and cancer progression; however, Pds5b the functions and molecular mechanisms of Pds5b in pancreatic cancer (PC) are unknown. Several approaches Ptch2 were conducted to investigate the molecular basis of Pds5b-related PC progression, including transfection, MTT, Invasion FACS, western blotting, wound healing assay, transwell chamber invasion assay, and immunohistochemical Growth methods. Pds5b overexpression inhibited cell growth and induced apoptosis, whereas the inhibition of Pds5b Pancreatic cancer promoted growth of PC cells. Moreover, Pds5b overexpression inhibited cell migration and invasion, while the downregulation of Pds5b enhanced cell motility. Furthermore, reduced Pds5b expression was associated with survival in PC patients.